Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Merck Sharp & Dohme Corp. v. Teva Pharmaceuticals USA Inc.
Case Number:
1:14-cv-00874
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
November 16, 2016
Teva Beats Merck Infringement Suit Over Valid Patent
A Delaware federal judge found Merck Sharp & Dohme Corp.'s asserted claims on its Nasonex patent valid on Wednesday, though she cleared Teva Pharmaceuticals of infringement allegations triggered by an abbreviated new drug application for a generic version of the popular nasal spray.
-
July 22, 2015
Teva Escapes Merck's Patent Suit Over Generic Nasonex
A Delaware federal judge on Wednesday dismissed Merck Sharp & Dohme Corp.'s suit claiming Teva Pharmaceuticals USA Inc. is infringing its patent by intending to produce and sell a generic version of the popular nasal spray Nasonex, adopting a magistrate judge's advice to toss the case.
-
July 01, 2015
Magistrate Urges Dismissal Of Merck's Generic Nasonex Suit
A Delaware magistrate judge on Wednesday recommended the court dismiss Merck Sharp & Dohme Corp.'s suit claiming Teva Pharmaceuticals USA Inc. is infringing its patent by intending to produce and sell a generic version of the popular nasal spray Nasonex.
-
July 03, 2014
Merck Sues To Block Teva's Generic Nasonex
Merck Sharp & Dohme Corp. sued Teva Pharmaceuticals USA in Delaware federal court on Thursday, alleging Teva's plans to manufacture a generic version of the popular nasal spray Nasonex infringe on Merck's patent on the drug.